Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ozlem Goker-Alpan

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
Molecular Genetics and Metabolism|September 6, 2011
Therapeutic approaches to bone pathology in Gaucher disease: past, present and futureOzlem Goker-Alpan
Therapeutics and Clinical Risk Management|July 30, 2010
Optimal therapy in Gaucher diseaseOzlem Goker-Alpan
Journal of Inherited Metabolic Disease|May 20, 2024
Neuronopathic Gaucher disease: Rare in the West, common in the EastOzlem Goker-Alpan, Margarita M Ivanova
Biomolecules|April 5, 2020
Effect of Substrate Reduction Therapy in Comparison to Enzyme Replacement Therapy on Immune Aspects and Bone Involvement in Gaucher DiseaseRenuka P Limgala, Ozlem Goker-Alpan
Journal of Biomedicine & Biotechnology|October 19, 2006
Gaucher disease and the synucleinopathiesKathleen S Hruska, Ozlem Goker-Alpan, Ellen Sidransky
Fetal and Pediatric Pathology|January 7, 2006
Perinatal lethal Gaucher disease: a distinct phenotype along the neuronopathic continuumMichael J Eblan, Ozlem Goker-Alpan, Ellen Sidransky
Human Mutation|July 25, 2016
New Directions in Gaucher DiseaseMia Horowitz, Deborah Elstein, Ari Zimran, et al.
Plos One|January 12, 2019
Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseasesMargarita M Ivanova, Erk Changsila, Chidima Iaonou, et al.
American Journal of Translational Research|January 22, 2019
Individualized screening for chaperone activity in Gaucher disease using multiple patient derived primary cell linesMargarita M Ivanova, Erk Changsila, Alper Turgut, et al.
International Journal of Molecular Sciences|October 2, 2020
The Interaction of Innate and Adaptive Immunity and Stabilization of Mast Cell Activation in Management of Infusion Related Reactions in Patients with Fabry DiseaseRenuka P Limgala, Jaqueline Fikry, Vasudha Veligatla, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
Molecular Genetics and Metabolism|September 6, 2011
Therapeutic approaches to bone pathology in Gaucher disease: past, present and futureOzlem Goker-Alpan
Therapeutics and Clinical Risk Management|July 30, 2010
Optimal therapy in Gaucher diseaseOzlem Goker-Alpan
Journal of Inherited Metabolic Disease|May 20, 2024
Neuronopathic Gaucher disease: Rare in the West, common in the EastOzlem Goker-Alpan, Margarita M Ivanova
Biomolecules|April 5, 2020
Effect of Substrate Reduction Therapy in Comparison to Enzyme Replacement Therapy on Immune Aspects and Bone Involvement in Gaucher DiseaseRenuka P Limgala, Ozlem Goker-Alpan
Journal of Biomedicine & Biotechnology|October 19, 2006
Gaucher disease and the synucleinopathiesKathleen S Hruska, Ozlem Goker-Alpan, Ellen Sidransky
Fetal and Pediatric Pathology|January 7, 2006
Perinatal lethal Gaucher disease: a distinct phenotype along the neuronopathic continuumMichael J Eblan, Ozlem Goker-Alpan, Ellen Sidransky
Human Mutation|July 25, 2016
New Directions in Gaucher DiseaseMia Horowitz, Deborah Elstein, Ari Zimran, et al.
Plos One|January 12, 2019
Impaired autophagic and mitochondrial functions are partially restored by ERT in Gaucher and Fabry diseasesMargarita M Ivanova, Erk Changsila, Chidima Iaonou, et al.
American Journal of Translational Research|January 22, 2019
Individualized screening for chaperone activity in Gaucher disease using multiple patient derived primary cell linesMargarita M Ivanova, Erk Changsila, Alper Turgut, et al.
International Journal of Molecular Sciences|October 2, 2020
The Interaction of Innate and Adaptive Immunity and Stabilization of Mast Cell Activation in Management of Infusion Related Reactions in Patients with Fabry DiseaseRenuka P Limgala, Jaqueline Fikry, Vasudha Veligatla, et al.
Pageof 9